$8.46 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 742 reported holdings in Q3 2012. The portfolio turnover from Q2 2012 to Q3 2012 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVH | New | COVENTRY | $31,816,000,000 | – | 763,158 | +100.0% | 63.61% | – |
| SHAW | New | SHAW GRO | $18,203,000,000 | – | 417,307 | +100.0% | 36.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| META PLATF | 36 | Q3 2023 | 2.3% |
| SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
| ACTIVISION | 29 | Q3 2023 | 71.3% |
| AMAZON COM | 29 | Q3 2023 | 0.8% |
| GAMING & L | 29 | Q3 2023 | 0.8% |
| SPDR S&P | 29 | Q1 2023 | 0.1% |
| DISNEY W | 28 | Q3 2021 | 2.0% |
| POST HLD | 27 | Q2 2020 | 1.8% |
| GENERAL | 27 | Q3 2022 | 1.4% |
| CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
| MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
| New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
| Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
| ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
| Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
| Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
| GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
| GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-06-06 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR/A | 2024-05-15 |
| 13F-HR | 2024-05-15 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.
Compare quarters
The following issues were detected while analyzing the report:
- The reported total value is incorrect (8458131000.0 != 50019000000.0)
- The reported number of holdings is incorrect (742 != 2)
- The reported has been amended
Export OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s holdings